Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
29.05
+0.56 (1.97%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $20.89 billion as of June 10, 2026. Its market cap has increased by 169.39% in one year.
Market Cap
20.89B
Enterprise Value
16.71B
1-Year Change
169.39%
Ranking
Category
Stock Price
$29.05
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $20.89B, an increase of 3,817.46%. That is a compound annual growth rate of 94.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 20.89B | 38.45% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 31.59B |
| Revolution Medicines | 31.57B |
| BeOne Medicines AG | 30.11B |
| BioNTech SE | 21.62B |
| Insmed | 20.41B |
| Incyte | 20.11B |
| Moderna | 18.89B |
| Genmab | 15.27B |